← 返回

TIL(肿瘤浸润淋巴细胞)与肿瘤的影像学表现

英文原题:Tumor infiltrating lymphocytes and radiological picture of the tumor.

查看英文原题

Tumor infiltrating lymphocytes and radiological picture of the tumor.

PubMed 2023/05/13(内容时间) Med Oncol Q2 · IF 4.7(JCR 2025)

分数与星级只用于站内排序 —— 不代表疗效、安全性或个人适用性。

中文摘要

肿瘤微环境(TME)是一个复杂的实体,除肿瘤细胞外,还包括一系列免疫细胞。在浸润肿瘤的各种免疫细胞群体中,TIL(肿瘤浸润淋巴细胞)(TILs)是一群以对肿瘤成分具有高反应性为特征的淋巴细胞。由于TILs在介导对多种类型治疗的反应中发挥关键作用,并在某些癌症类型(例如乳腺癌和肺癌)中显著改善患者预后,因此其评估已成为评价潜在治疗疗效的良好预测工具。目前,TILs浸润密度的评估通过组织病理学进行。然而,近期研究揭示了多种影像学方法在评估TILs水平方面的潜在用途,包括超声、磁共振成像(MRI)、正电子发射断层扫描-计算机断层扫描(PET-CT)和放射组学。关于放射学方法实用性,最受关注的是乳腺癌和肺癌,尽管如此,针对其他恶性肿瘤的TILs影像学方法也在不断发展。在此,我们重点综述用于评估不同癌症类型中TILs水平的放射学方法,以及提取每种方法所评估的最有利放射学特征。

展开英文摘要原文

Tumor microenvironment (TME) is a complex entity that includes besides the tumor cells also a whole range of immune cells. Among various populations of immune cells infiltrating the tumor, tumor infiltrating lymphocytes (TILs) are a population of lymphocytes characterized by high reactivity against the tumor component.

As, TILs play a key role in mediating responses to several types of therapy and significantly improve patient outcomes in some cancer types including for instance breast cancer and lung cancer, their assessment has become a good predictive tool in the evaluation of potential treatment efficacy. Currently, the evaluation of the density of TILs infiltration is performed by histopathological.

However, recent studies have shed light on potential utility of several imaging methods, including ultrasonography, magnetic resonance imaging (MRI), positron emission tomography-computed tomography (PET-CT), and radiomics, in the assessment of TILs levels. The greatest attention concerning the utility of radiology methods is directed to breast and lung cancers, nevertheless imaging methods of TILs are constantly being developed also for other malignancies.

Here, we focus on reviewing the radiological methods used to assess the level of TILs in different cancer types and on the extraction of the most favorable radiological features assessed by each method.

论文信息

作者
Frankowska K、Zarobkiewicz M、Dąbrowska I、Bojarska-Junak A
第一作者单位
Department of Clinical Immunology, Medical University of Lublin, Lublin, Poland.Poland
通讯作者单位
Department of Clinical Immunology, Medical University of Lublin, Lublin, Poland. michal.zarobkiewicz@umlub.pl.Poland
文献类型
综述
期刊
Medical oncology (Northwood, London, England)2023 May 13
原文标识
PubMed 37178270 · DOI 10.1007/s12032-023-02036-3